Paying users zone. Data is covered by hidden.

  • Get to Abbott Laboratories for $19.99, or

  • get to entire website for at least 3 months from $49.99.


Visa Mastercard Maestro American Express Discover JCB    PayPal

Microsoft Excel LibreOffice Calc

Abbott Laboratories (ABT)


Statement of Financial Position, Assets

Difficulty: Beginner

The statement of financial position provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Abbott Laboratories, Consolidated Statement of Financial Position, Assets

USD $ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Cash and cash equivalents hidden hidden hidden hidden hidden
Investments, primarily bank time deposits and U.S. treasury bills hidden hidden hidden hidden hidden
Trade receivables, less allowances hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Deferred income taxes hidden hidden hidden hidden hidden
Other prepaid expenses and receivables hidden hidden hidden hidden hidden
Current assets held for disposition hidden hidden hidden hidden hidden
Current assets hidden hidden hidden hidden hidden
Equity securities hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Long-term investments hidden hidden hidden hidden hidden
Net property and equipment hidden hidden hidden hidden hidden
Intangible assets, net of amortization hidden hidden hidden hidden hidden
Goodwill hidden hidden hidden hidden hidden
Deferred income taxes and other assets hidden hidden hidden hidden hidden
Non-current assets held for disposition hidden hidden hidden hidden hidden
Non-current assets hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).


Assets, Selected Items

Item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Abbott Laboratories’s current assets declined from 2016 to 2017 and from 2017 to 2018.
Net property and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Abbott Laboratories’s net property and equipment increased from 2016 to 2017 but then slightly declined from 2017 to 2018.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Abbott Laboratories’s non-current assets increased from 2016 to 2017 but then slightly declined from 2017 to 2018.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Abbott Laboratories’s total assets increased from 2016 to 2017 but then slightly declined from 2017 to 2018.

Current Assets, Selected Items

Item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Abbott Laboratories’s cash and cash equivalents declined from 2016 to 2017 and from 2017 to 2018.
Investments, primarily bank time deposits and U.S. treasury bills Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. Abbott Laboratories’s investments, primarily bank time deposits and U.S. treasury bills increased from 2016 to 2017 and from 2017 to 2018.
Trade receivables, less allowances Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Abbott Laboratories’s trade receivables, less allowances increased from 2016 to 2017 but then slightly declined from 2017 to 2018.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Abbott Laboratories’s inventories increased from 2016 to 2017 and from 2017 to 2018.